Evan Bryson

Evan Bryson is an Adjunct Assistant Professor in the Department of Pharmacy Practice and Science at the University of Kentucky. He practices clinically at the Markey Cancer Center, specializing in lung, head, neck, and gastrointestinal oncology. His academic responsibilities include precepting pharmacy students and residents in ambulatory/inpatient oncology rotations and contributing to the therapeutics curriculum.

Education:

• Doctor of Pharmacy, Presbyterian College School of Pharmacy
• PGY1 Pharmacy Residency, Norton Healthcare
• PGY2 Hematology/Oncology Residency, Emory Healthcare

Research Focus: Dr. Bryson investigates oncology supportive care strategies, precision medicine applications, immune-mediated adverse events, and post-marketing safety profiles of small-molecule inhibitors. His work bridges clinical pharmacy and translational research to optimize cancer therapeutics.

Publication Trends: His recent articles (2014–2022) emphasize oncology pharmacology, including drug delivery optimization (e.g., topical gabapentin/cyclobenzaprine), chemotherapy safety/efficacy (capecitabine, melphalan), and management of targeted therapy complications (ALK inhibitors).

Scientific Awards: No awards reported.

Advising & Grants: Actively mentors pharmacy students and residents but no named advisees or funded grants documented.